Covid-19 Update
Lisa Cameron Excerpts(2 years, 11 months ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Sajid Javid
I think my hon. Friend will understand the difference in terms of public health between a managed quarantine facility and home quarantine, but he is right to point to an important issue. Of course no one is going to enjoy being quarantined in this way—why would anyone? I think everyone understands the issues, but it is really important that the quality of care provided there is equally decent and of good quality. If my hon. Friend can share with me some of the information he has about his constituents, I would like to look into that.
Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (SNP)
As chair of the all-party disability group, I have been hearing from people right across the United Kingdom saying that some of the individuals who have not yet been vaccinated have learning disabilities or autistic spectrum disorders. They have a fear of going to large-scale vaccination centres but do not yet have adapted vaccination regimes with specialist learning disabilities nurses who can attend to them. Could the Secretary of State assure the House that this will be taken forward and that the most clinically vulnerable will not be left behind?
Sajid Javid
It is important that there is easy access for everyone to get vaccinated. The hon. Lady has given a really good demonstration of why that is so critical for every part of our community. If it is helpful, the Vaccines Minister will be pleased to meet her, as chair of the APPG, to see what more we can do.
Medical Cannabis: Alleviation of Health Conditions
Lisa Cameron Excerpts(3 years ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Alex Norris (Nottingham North) (Lab/Co-op)
I thank the Backbench Business Committee for granting this important debate and the hon. Members for Inverclyde (Ronnie Cowan), for Edinburgh West (Christine Jardine) and for Reigate (Crispin Blunt) and my hon. Friend the Member for Gower (Tonia Antoniazzi) for securing it. I also thank the cross-party campaigners in this place beyond that group, including the hon. Member for South Leicestershire (Alberto Costa), the right hon. Member for Hemel Hempstead (Sir Mike Penning) and my hon. Friend the Member for Manchester, Withington (Jeff Smith), for all that they have done over the years to put it on the parliamentary agenda.
Progress in making cannabis-based medical products available to those who need them has been slow, so it is right that we have the opportunity to debate the frustrating lack of progress. As hon. Members have said, this is the second debate in two days, which I hope gives those watching confidence that we in this place are taking the issue seriously.
I associate myself with the remarks of the hon. Member for Inverclyde in his opening speech about the families who are dealing with incredible, unthinkable challenges and who handle themselves with such dignity and make such powerful cases. I hope—I feel—that we have done them justice today and will continue to do so. In particular, I hope that the Minister will touch on his points about the limiting factors in research.
The speech of the hon. Member for Reigate was a characteristic tour de force. I always stop to listen when he is talking about the issue, because he speaks with such power. He made the point that it is unacceptably cruel to take effective medicines away from a child, which we all agree with. He linked that to palliative care, and I share the view that we want people at the end of their life to get whatever treatment might make their final days the best that they can be. Actually, that applies to adults throughout their lives: if people are living in pain and do not have to be, I would want to do anything I could to avert that.
The hon. Gentleman spoke about the 2018 regulations and the sense that we thought they had solved it, as the right hon. Member for New Forest East (Dr Lewis) also said. The hon. Member for Reigate gave us a hopeful way forward by concluding that we need to be creative and solution-focused. The Opposition share that view—I do not think there is a lot of politics on this issue—and support coming together to find a practical, effective, safe and risk-aware solution.
My hon. Friend the Member for Manchester, Withington spoke in that spirit. He is fortunate to have been drawn in the private Member’s Bill ballot, which is precious for any right hon. or hon. Member. He is keen to work with the Government. I know him well and know the spirit in which he will work with them, so I hope the Minister will take that up. That private Member’s Bill would be a perfect vehicle to move the issue forward. His point that it is about not just epilepsy was well made. I double underlined the phrase that we need to give clinicians the “comfort to prescribe”, which was elegantly put. I completely support that goal and will come back to it.
The hon. Member for Edinburgh West spoke about her constituency case of Murray. Many right hon. and hon. Members will recognise similar cases in their surgeries. The daftness of that story is that the UK’s prescribing could grind to a halt on the basis of a single person retiring. Where else in the health service would that ever be the case or tolerated? It is an absurd set of affairs.
My hon. Friend the Member for North Tyneside (Mary Glindon) kindly facilitated the opportunity for me to meet her constituent, who is a doughty campaigner, as she says. To hear the impact on her constituent’s life, it is hard to understand why we are not doing everything we can to make sure that she can live with as little pain as possible. I will get on to the counterargument about the lack of evidence, but she is that evidence, because we know what her life was like before and after, so I find that argument hard to accept.
The common theme of the contributions has been frustration or, more positively, a desire to redouble our efforts in this area, which cuts both ways. There are opportunities in research, which I hope the Minister will talk about, with regards to epilepsy, long-term pain relief and mental health. We also need a stronger position on the regulation of products such as cannabidiol, which proliferate on the internet and can be found in various shops, in all sorts of forms, promising all sorts of things that are hard to establish. We need better regulation in that space.
When the Government accepted the therapeutic use of cannabis, it was met, as we have heard, with much relief from campaigners, such as the families of Billy Caldwell and Alfie Dingley, who has now gone 508 days without an epileptic fit thanks to his medicinal cannabis treatment. It has changed his life, but not everyone has been so lucky.
Bailey Williams has been denied access to medicinal cannabis for his epilepsy and his parents are forced to raise £1,200 a month for his treatment. The mother of 11-year-old Teagan Appleby spends about £2,000 a month to treat her daughter’s Lennox-Gastaut syndrome, as she has not received a prescription. In the time that she has been taking that treatment, she has to go to hospital only once—when it ran out. That is the impact on her life.
I think of my constituents and how few, if any, could spare £2,000 a month. Of course, all of them, and I daresay all of us, would go to whatever lengths necessary for our children—that is the tragic paradox—but it is not acceptable. We are letting people down on an issue that we thought we had resolved.
In 2018, cannabis-based products were rescheduled. Guidelines were produced by the National Institute for Health and Care Excellence and three products got through: Epidyolex for rare forms of epilepsy, Nabiximols for multiple sclerosis-related spasticity and Nabilone for side effects from chemotherapy. The regulations said that initial prescriptions must be made by a specialist medical practitioner and, in all cases, would be considered only when other treatments were unsuitable or had not worked.
Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (SNP)
The hon. Gentleman is making an excellent point. Does he agree that the psychological pressure and stress of having to campaign constantly and raise money at that level is simply unfair? My constituent Lisa Quarrell has had to raise thousands of pounds for her child Cole Thomson and has been under that stress continually for years. It is time for us to work collectively to overcome any hurdles to achieving success.
Maria Caulfield
I take the hon. Lady’s point, but the MHRA, which is the regulator, and other regulators around the world have a tier of research that they will accept. The randomised controlled trial method is the gold standard, and the more randomised controlled data someone has, the more likely they are to get a trial approved quickly. Of course observational studies will be used. That is why, if researchers have a large group, want to do observational studies—we heard about the Sapphire clinic from the hon. Member for Inverclyde—and come forward with observational data, I encourage them to speak to the MHRA to see whether that is the sort of research that would be acceptable. It is important that they have those discussions with the regulating body, because it may well accept some of that evidence.
Until manufacturers, researchers, academics and those using these drugs in practice come forward with whatever research they feel would be acceptable and have those discussions, we will go round in a circle. I am keen that if observational studies are acceptable, we support them to happen. Whatever it takes, in research terms, to get a licence through, the Government are there, providing funding, advice and support. However, ultimately, they are not the body that can make that decision; but I think there is a willingness around the House to try to find a resolution.
It will take time to generate further evidence and see the results of clinical trials. The Health Secretary and I are committed to doing everything in our power to accelerate this work. There have been some helpful suggestions this afternoon that we may need to go away and look at.
I thank everyone again. Although this is the second debate on this subject in two days, I know that it will not be the last; the private Member’s Bill will come forward next month. I want to put on the record my commitment to this issue. It is extremely difficult. In yesterday’s debate, we heard constituents’ stories relayed by their MPs, including the hon. Member for Middlesbrough (Andy McDonald). They really are very moving testaments, and we want to find a way forward. We have changed the law, but that has clearly not been enough. We need to find a resolution, so that we can get these medications licensed if the clinical evidence is there, and we need to work with the regulator.
Dr Cameron
I know that the Minister is committed to this issue. Could the Government perhaps appoint a lead clinician for this issue, to give clinicians across the United Kingdom confidence, and to drive the issue forward at pace, so that we see movement in the short term?
Maria Caulfield
The hon. Lady makes a good point. If there are clinicians who want to take a lead on this, there is obviously scope to look at that, but we must be clear that we have to license and support research for this medicine in the way we would any other. I have given a commitment today to working with hon. Members on both sides of the House to demonstrate how seriously the Government take this issue.
Baby Loss Awareness Week
Lisa Cameron Excerpts(3 years, 1 month ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Angela Crawley (Lanark and Hamilton East) (SNP)
I did not expect to be called to speak so early in the debate; thank you, Madam Deputy Speaker.
I again thank my friend, the hon. Member for Truro and Falmouth (Cherilyn Mackrory), for her bravery and for sharing her experience on the Floor of the House. It matters to the people at home to know that we politicians are also human beings, and that we also feel grief and loss.
Whether a pregnancy was planned or a surprise, that moment of seeing two lines on a pregnancy test stick will stay with many parents for a lifetime. Equally, for many who are trying to conceive, a faint one line or “not pregnant” will stay with them also, each and every time they receive it. Pregnancy can be a joyous, happy celebration for many. Perhaps that is why we often choose not to speak of the sadness and heartbreak when a pregnancy loss happens. Tragically, one in four pregnancies will end in miscarriage. The experience of miscarriage, along with the grief and loss associated with the miscarriage or stillbirth, will resonate for one too many parents. Every pregnancy loss is different, and there is no right or wrong way to feel about it. Sadly, many patients feel stigma. They feel a sense of shame or a failure that they could not conceive or, even when they can, that the pregnancy does not result in a happy birth.
Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (SNP)
My hon. Friend is making an excellent speech that resonates with so many of us who have suffered baby loss. Will she commend, with me, the campaign run by my constituent Louise Caldwell? She is campaigning for a dedicated miscarriage unit after having to give birth to her child who was sadly lost, not in a miscarriage way, and suffering real compounded trauma from having to be in the maternity wing of the hospital while other parents were celebrating and she was bereaved and her whole family were devastated? Will she also congratulate the Scottish Government on taking forward an initiative to have dedicated miscarriage wings?
Angela Crawley
I thank my hon. Friend for raising that very valid point. I commend Louise for her bravery and for making sure that the Scottish Government will adopt a new policy to prevent people in future from having to undergo that experience of happiness in among the sadness at that very tragic moment.
Many partners will blame themselves and often feel helpless in this situation. Thanks to the work of my hon. Friends the Members for North Ayrshire and Arran (Patricia Gibson) and for Glasgow East (David Linden), only last year bereavement legislation was introduced that entitles parents who lose a baby after 24 weeks to two weeks’ paid bereavement leave. However, there is currently no provision in place for parents who lose a baby before 24 weeks. Too many parents—mothers, fathers, partners and any parents who are facing this tragic incident—are forced to take sick leave or unpaid leave. Understandably, many do not wish to disclose these private and intimate details to their employer, especially in the early stages of pregnancy.
Grief is not an illness. In and of itself, it is a process that parents must go through. There is simply no timeline for grief. Every parent, regardless of whether the loss happens after 24 weeks or before, should be given the time to grieve that loss without a financial penalty. That is why I have introduced a private Member’s Bill that would allow parents who experience a miscarriage before 24 weeks to seek a minimum of three days’ paid leave. Some companies have already gone further, offering leave for seven to 14 days—an example that I hope many more employers will replicate and that I absolutely welcome. This compassion and recognition of the loss and the grief that comes with a miscarriage, whether in policy or in statute, would allow parents to approach their employer and seek a legal right to paid leave.
This traumatic life event will inevitably affect both parents differently. There is a cost associated with such a loss, as many parents opt to take unpaid or sick leave, so there is already a financial penalty for people up and down the country. Often an employer has no idea what the nature of their employee’s sickness is, or the ramifications for their business. Therefore, having a policy on this issue, or the right to take paid leave in statute, should not add any further burden to them. Rather, it would allow the conversation to take place where both employee and employer can understand the situation and hopefully seek to support their employee in the best way that they can. Many parents have spoken of feeling isolated and alone, without the opportunity to share their loss with colleagues for fear of the shame and stigma that have been associated with such a loss. Introducing a minimum of three days’ paid leave would not only give parents a chance to grieve and process their loss but show everyone that miscarriage is no one’s fault and help to break that stigma.
Future of the National Health Service
Lisa Cameron Excerpts(3 years, 1 month ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (SNP)
It is a pleasure to serve under your chairmanship for the first time, Ms Bardell. I commend the hon. Member for Leeds East (Richard Burgon) on a remarkably important debate, not just in terms of timing, but in everything the four nations have gone through in the past 18 months, which has underlined for all of us how crucial the NHS is. It is there at our time of need and it is there in our time of crisis as well. We owe a great debt of gratitude to the NHS and its staff. Members from all parties must prioritise and defend the NHS and ensure that those staff have our support moving forward, just as they supported us in our time of crisis.
The hon. Member for Leeds East spoke eloquently about the dangers of privatisation creeping into the NHS and about accountability reducing for local patients. He used the phrase that I used to hear as a union rep in the NHS and which created great fear: the NHS was no longer the preferred provider. That is extremely important because, as other Members have said, it means corporations can bid for NHS services and contracts and cherry-pick the most cost-effective ones, leaving the most complex and vulnerable patients to the NHS and placing it under even greater strain. I thank him for setting that out as the crux of today’s debate.
The hon. Member for Strangford (Jim Shannon) thanked all of our NHS staff and heard the clapping for them and those on the frontline during the pandemic. He also made an excellent point about the fact that available medications in Northern Ireland are sometimes not equal to those available on the mainland. That is not what should be at the heart of the NHS system; it should be about equality of access, and I would be pleased if the Minister responded to that point about Northern Ireland.
The hon. Member for Streatham (Bell Ribeiro-Addy) spoke about the impact of covid-19, and, once again, about privatisation. The hon. Member for York Central (Rachael Maskell) spoke about how equality of service at the point of access is not just about treating illness; it is about wellbeing and dealing with life’s inequalities and day-to-day inequalities in our system and our country as a whole. She spoke about the backlog in the system due to covid-19 and how this has led not just to a staffing and workforce crisis, but to many people who need urgent treatment perhaps falling through the gaps. We must plug those gaps urgently for anyone who may be affected.
The hon. Member for Rhondda (Chris Bryant), who always speaks eloquently about brain injury, did not mention acquired brain injuries today. I must confess that my husband has suffered a brain injury, so I am always grateful to the hon. Member for bringing it to the fore. It is often overlooked, and is one aspect of the NHS that we must seek to fund. It is also much wider than that; it is part of our armed forces covenant and affects our veterans and those in criminal justice services. The hon. Member gave very practical solutions today, which I think is always helpful, on staffing retention and recruitment. Those are the very practical aspects of care and treatment that the Minister will have to grapple with and take forward. I thank him once again for that today.
The hon. Member for Liverpool, Wavertree (Paula Barker) spoke about the potential for interference in contracts due to the Secretary of State’s additional powers. Given some of the decisions made during covid, and some of the funding that was perhaps not best utilised, I think that is something that concerns us all across the House. We must focus on that, to ensure that the NHS provides good value for money, and that there is not any interference with the making of clinical best-practice decisions.
The hon. Member for Wirral West (Margaret Greenwood) spoke about a postcode lottery in NHS England, and really set it out with her example of life and death before our NHS and what that meant for most people across the United Kingdom. We should never lose sight of that, because that is the crux of why our NHS is so important, so special, and why we must protect it with everything that we have.
The hon. Member for Bolton West (Chris Green) spoke about rare conditions and the importance of international trials and collaborations, which is an extremely important point. Yes, we must protect our NHS, but we must also incorporate innovation, in a safe way, into our NHS structures, to ensure that our patients have the best treatments possible, and a choice in the types of treatment that they believe would be effective for them. We must, of course, undertake drug trials and, particularly for rare conditions, those must involve international collaborations. Otherwise, we would not have enough participants in the United Kingdom alone.
It has been an excellent debate. In the few minutes that I have left, I will say that the NHS is about health and clinical care, but it is also about mental health. It is important that we come out of this pandemic knowing that it is about wellbeing—it is a wellbeing recovery, and we must focus very much on mental health. I therefore hope that the Government will bring forward an announcement on the new mental health spokesperson in the near future. That is something that should be prioritised. I am sorry that it has not happened before now.
I would also like to mention a bit about what is happening in Scotland. The Scottish Government will increase NHS frontline spending by at least 20% to support the recovery and renew Scotland’s NHS. That builds on the Scottish Budget of 2021, which took the total health portfolio spend to £16 billion, in an increase of more than £800 million. The Scottish Government have also developed the NHS Pharmacy First Scotland scheme, placing local pharmacies at the heart of frontline provision. I went to visit Abbeygreen, a local pharmacy in my constituency, which is doing a lot of excellent work on the frontline, protecting resources for GP services and ensuring that people can access medications extremely rapidly.
I am always keen that we support best practice across the four nations and I do not think the NHS should be a political football. When I worked there, we always dreaded changes because they meant more admin and sometimes did not change the service but just gave more work to those who were already stretched. I would like to see things such as Pharmacy First, which is working extremely well in Scotland, being something that the Minister might consider and discuss with colleagues there. There are best practice examples right across the United Kingdom that we can all seek to replicate, which is extremely important.
NHS Scotland staff remain the best paid anywhere in the UK and this year “Agenda for Change” staff, including nurseries, ancillary administration and allied health professionals, received a 2.95% pay rise as part of a three-year pay deal offering a minimum 9% pay increase for more staff and more than 27% for some still moving up their pay scale. That was in excess of a 2.8% uplift. The Scottish Government are also seeking to abolish NHS dentistry charges, eye examination costs and non-residential social care charges for those in need of support. There is great progress being made.
I think everyone has come to the debate with the real value of the NHS in their heart and in their speeches. Collaborating, working together and sharing best practice right across the board, and making sure we protect our NHS, that the NHS is the preferred provider in the future and that we seek to protect it from private contracts, is going to be extremely important in supporting the staff who have given their all. We need to do that and we need to work together and collaborate to do that. I know that people across the House want to champion the NHS into the future. I look forward to the responses from the shadow Minister and the Minister.
Edward Argar
With the meeting or the job, or both? A number of hon. Members have raised “Agenda for Change” and pay and conditions. I hope I can reassure them, as I sought to do with the hon. Member for York Central (Rachael Maskell). It is not our intention that integrated care boards depart from “Agenda for Change”. The Bill is drafted in such a way as to seek to replicate what is currently there. On Second Reading, I offered to have a meeting with her. I would be very happy to have that meeting, if she gets in touch.
On funding, this Government have passed legislation increasing NHS funding by £33.9 billion by 2023-24 and put £2 billion into elective recovery. In addition, the Prime Minister announced a massive cash injection into our NHS a couple of weeks ago.
I want to give the hon. Member for Leeds East a little time at the end, so I will just make a couple of quick points. The hon. Member for East Kilbride, Strathaven and Lesmahagow (Dr Cameron) is right: we are always happy to learn from our Scottish friends. In response to the hon. Member for Strangford (Jim Shannon), that is a matter of medicine supply which I discuss regularly with the Northern Ireland Health Minister, and it is absolutely vital that we seek a resolution. I believe that the previous approach by Lord Frost is the right one to find a sustainable way forward.
Dr Cameron
On sharing best practice, I meant to mention that artificial intelligence technology is being used by NHS Greater Glasgow and Clyde and has reduced the heart failure diagnostic waiting times from 12 months to six weeks. I know that Lord Bethell will be visiting to find out more about that. I wanted to highlight it to the Minister today, because I think that technology can support NHS staff workload as we move forward.
Edward Argar
The hon. Lady has rightly highlighted the benefits of technology, while my hon. Friend the Member for Bolton West (Chris Green) highlighted the need for us to continue to move with the times and seize those initiatives. I fear that my noble friend Lord Bethell will not be visiting, as he left the Government at the end of last week. However, I have received a very kind invitation from the hon. Member for Central Ayrshire (Dr Whitford) to come and see how the NHS in Scotland is innovating and driving change. I look forward to taking her up on that invitation as soon as I can.
Medicinal Cannabis
Lisa Cameron Excerpts(3 years, 1 month ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Jim Shannon (Strangford) (DUP)
I congratulate the hon. Member for Edinburgh West (Christine Jardine) on bringing this debate forward, and it is a pleasure to follow the right hon. Member for Hemel Hempstead (Sir Mike Penning). He is a man who speaks with great passion for what he believes in, and I have been very fortunate to be able to support him in bringing this issue forward.
I rise to speak about one of my constituents. Darren and Danielle are the parents of little Sophia. I have absolutely no doubt that the reason why Sophia has improved so fantastically, way beyond what we ever hoped, is because of medicinal cannabis. Parents, as parents do, speak for their children and want the best for them. I brought Danielle over here and we met the previous Health Minister, who heard her story for the first time. As a result of hearing that story, he did his best to help us move forward to the next stage. A lot of people have helped. We would never have done any of these things without myriad people, including the right hon. Member for Hemel Hempstead and his friends and colleagues. Sophia is a lovely bright wee girl whose life was a litany of multiple seizures. She is a different girl today because of medicinal cannabis. I am very clear about what I want to see in relation to medicinal cannabis. I see its specific benefit for young people.
I am very fortunate to be a member of many organisations back home. One is the Royal Black Preceptory, and who were there at the side of the road in Newtownards on the last Saturday in August but Sophia, Danielle and Darren? That wee girl, who I had not seen for ages—for a couple of years at least, because of covid—was at the side of the road and she was as bright as a bean. Her mum and dad were pointing me out in the parade so they could say thank you for all we had done. Honestly, what did we do? All we did, really, was what any parent would do for their child, and that is what it is all about.
Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (SNP)
I thank the hon. Gentleman for giving way and for pointing out just what it means to families to have this opportunity. In my own constituency, Cole Thompson and his mother Lisa Quarrell have really fought and campaigned to pay for this medication. Aside from the financial costs, I hope he agrees that we must also recognise the psychological stress and turmoil we are continually putting these families through month after month after month. It really is incumbent on the Government to address that, because it is simply not fair: it is not fair on the children and it is not fair on the families.
Jim Shannon
I thank the hon. Lady for her intervention. That is exactly how I feel, and I think it is exactly how we all feel as elected representatives on behalf of our constituents. I can well recall the bad old days of the pressure that was on the family: the pressure on the parents, the pressure on the child and the pressure on their friends, with all the multiple issues they had to address. There is an evidential base. It is as clear as a bell. I can see it in that wee girl Sophia. I can see it in the improvement that she has quite clearly made. That is why I totally support this product. I believe the evidential base is overwhelming. I can vouch for that, as I see that lovely wee girl and the improvements she has had.
My hon. Friend the Member for Belfast East (Gavin Robinson) sent me a letter, which I will record for Hansard if I can, written by his constituent, a fellow called Robin Emerson, whose daughter is a wee girl called Jorja. There is also an evidential base in her improvement. My hon. Friend very kindly gave me a copy of the letter last week, which refers to
“an important intervention to enable a number of children suffering with epilepsy to receive a treatment containing Cannabidiol (CBD) and Tetrahydrocannabinol (THC). This has made a crucial difference to their quality of life over the past two years”.
In some cases, quite honestly Mr Speaker, I believe they save lives. They definitely do. In my heart I believe that, which is why I am here tonight to speak on this matter. I feel it is so important.
Jo Churchill
All three Members rose at the same time. I will make my next point before I take interventions.
While the evidence base remains limited, I am sure that everybody, including clinicians in this place, will agree that decisions on whether to prescribe, as with any other medicine, have to remain clinical decisions. A doctor would not appreciate me in their consulting room telling them that they did not know their job as a doctor.
Jo Churchill
I would like to reassure the hon. Lady that we do look elsewhere, but it fundamentally comes back to the fact that observational trials on very small cohorts are not the best way to develop the policy, going forward, to treat these individuals. That is notwithstanding the fact that the observations of all the parents I have met, and others who have seen their children benefit, are the foundation for making us try to put our shoulders to the wheel in order to do better. I think there is that tension.
Looking across other countries, my hon. Friend the Member for Windsor (Adam Afriyie) said, “If they can do it, why can’t we?” What is needed to support routine prescribing is the evidence base of safety and efficacy, public funding and cost-effectiveness. This is the system that we use in the UK for all medicines and medical devices, and it is really difficult to see a case for why cannabis should be treated differently from that on a broader spectrum, particularly when we take into account the comment by my hon. Friend the Member for Reigate (Crispin Blunt) that there is a need to look at how these medicines may help others suffering from chronic pain. I have been told that multiple sclerosis and palliative care are other areas, and so on. If we are going to broaden this, then we must look to do the job properly.
Dr Cameron
I thank the Minister for grappling with what is a very complex matter. I totally understand what she is saying. I can understand some clinicians’ reluctance because they do not want to prescribe something when they do not know what is contraindicated in relation to other conditions and they do not want to do harm. But this must potentially be done where the children are already benefiting from some kind of expedited process to ensure that they can have the prescriptions and that parents are not having to try to fund that in so many different ways, causing that stress. There must then be some kind of expedited clinical trial that shows that clinicians more broadly can have the confidence that they are prescribing medications that will support conditions, do no harm and would not be contraindicated or cost children or adults their lives if prescribed to the wrong individuals.
Jo Churchill
I thank the hon. Lady because she encapsulates in a nutshell what the challenges are. This is extremely difficult without that knowledge of what the contraindications are. I was trying to suggest, perhaps not as eloquently as I could have done, that we need these different bits in order to make the policy work. As the House has heard, the current Health Secretary was the Home Secretary when he changed the law, and at our very first meeting, he told me it was one of the things he was very keen to see us move forward on.
Covid-19 Update
Lisa Cameron Excerpts(3 years, 1 month ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Nadhim Zahawi
I am grateful for my right hon. Friend’s excellent question. I would say two things: first, in many ways, the decision taken by our chief medical officers in England, Wales, Scotland and Northern Ireland to increase the dosing interval, including for the vaccine that Israel uses—the Pfizer vaccine—from three to 12 weeks, with it now at an optimal eight weeks, was actually an inspired and clinically incredibly important decision, because it demonstrates, in real-world data, that the durability of the protection is increased over people who have had two jabs with a three-week dosing period. So we are in a slightly more advantageous position, if I can describe it as such.
My right hon. Friend makes an important point on boosters. The booster programme is probably the most important piece of the jigsaw yet to fall into place before we can transition this virus from pandemic to endemic status. I reassure him and the House that the NHS has all the plans in place to deliver the booster programme in what will, in some weeks, probably break our record, which we set in phase 1 of the vaccination programme. The JCVI has given us its interim advice on who needs to boost. It has added, obviously, the immunosuppressed to categories 1 to 4 and it has rightly recommended that we go big on flu. I am equally worried about that. Flu has been non-existent because of the severe social isolation of lockdowns and a big flu season could be detrimental as well. We are ready to go. As soon as cov-boost reports, which is imminent, we will be able to operationalise a massive booster programme.
Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (SNP)
I thank the Minister for his statement and the update on the vaccination roll-out for pregnant women and the roll-out to young people and those who are most clinically vulnerable. I thank our NHS staff across the four nations, who have dealt with wave after wave of the pandemic and are now at the forefront of the vaccination strategy.
We welcome the additional funding and I seek reassurance from the Minister that, particularly when it comes to young people, there is a holistic approach, so that we deal with not just the physical health aspects, but the mental health aspects. As the chair of the all-party parliamentary health group, I have been inundated with concerns from people across the United Kingdom who cannot access services for young people with eating disorders, for those who self-harm and require crisis intervention, and for those who require the diagnosis of autistic spectrum disorder to receive the support that they need. The Royal College of Psychiatrists has described a “mental health crisis” that could plague the current generation of children for years to come. Will the Minister acknowledge that a holistic approach is needed, alongside the vaccination strategy, to make sure that we support young people’s mental health and mental health across the generations, as well as to make sure that the funding also reaches the mental health needs of the population at large?
Nadhim Zahawi
I am grateful for the hon. Lady’s words of support and for her focus, quite rightly, on mental health. She will know that prior to today’s announcement of £5.4 billion, we also delivered £270 million to primary care for GPs to deal with capacity issues, because they are dealing so well with the covid vaccination programme. However, she makes a very important point that we are very cognisant of and focused on.
Dementia Action Week
Lisa Cameron Excerpts(3 years, 5 months ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (SNP)
It is an absolute privilege to speak in this debate today, and to follow the hon. Member for Scunthorpe (Holly Mumby-Croft). She spoke so poignantly about her family’s journey with dementia care, and some of the issues that require to be addressed to improve that journey. Having such expertise in the House is excellent, because this issue will touch so many of our lives and it is important to bring the human aspect to dementia care.
We should remember, as we have all grappled with health issues over the past year, that wellbeing should also be at the forefront of the work we do, and that psychological and mental health are important alongside physical health needs. Certainly, in relation to older adults in care homes who have not been able to see relatives and the relatives who have much missed that contact too, we are going to have to learn lessons from best practice right across the United Kingdom and have a key focus on wellbeing alongside that on physical health.
Dementia is a progressive, long-term health condition that affects about 90,000 people in Scotland currently. The Scottish Government are really committed to delivering a modern social care service for the 21st century, including building a national care service that will benefit people living with dementia, their families and carers. It is also my honour to speak today on behalf of the 5,322 people who live in my local NHS Lanarkshire health board who have been diagnosed with dementia, and on behalf of their relatives and loved ones, and the social and healthcare workers who care for them every single day with such dedication. I would also like to mention the East Kilbride & District Dementia Carers Group, which we hope will be up and running again as soon as possible, in line with the restrictions, because it provides the benefit from social communication, building self-esteem, confidence and social integration that people need, alongside having their physical health needs met.
I want briefly to raise the issue of those who have not yet been diagnosed with dementia. We know there was a drop of about 6% in diagnosis rates between the start of 2020 and February 2021 due to this pandemic. Accurate early diagnosis is absolutely crucial in identifying suitable candidates for clinical trials and available medication, which is most effective at the start of a dementia pathway. So it is very important that we have investment and support to get people diagnosed as early as possible, and that that is doubled up on in coming out of the pandemic. Alzheimer’s Research UK estimates that 1.3 million people in the UK will be living with dementia by 2030, so it is of paramount importance that we do everything we can to ensure they have the best treatment and care possible.
The Scottish Government published the dementia and covid-19 action plan in December 2020 to build on and continue to expand the national action, since March 2020, on supporting people with dementia and their carers. This plan recognises the significant impact of the pandemic and the necessary response for people with dementia and their carers, and sets out 21 commitments to assess impact and respond to the needs of this group across all care settings at diagnosis and all parts of the dementia care journey.
We are very proud to be the only country in the UK with free personal care, which is extremely important in supporting people under the financial strains that dementia and living with dementia can place on families. The Scottish Government invested £700 million in 2019-20 to support free personal care for older people in Scotland, and extended it in April 2019 to all those under 65 who have a diagnosis of early dementia. There is a plan to increase social care investment by 25% over this Parliament, which is equivalent to over £840 million.
We are also extremely proud to have ensured a living wage of at least £9.30 per hour for social care staff. While we have been rightly clapping everybody in NHS and care settings every week, it is important that they are also financially rewarded for their excellent work. In this toughest of years, the Scottish Government have also included social care workers in the £500 bonus thank you payment, which they launched for NHS and care workers during covid.
I want to finish with another push for psychological therapies, and I refer the House to my entry in the Register of Members’ Financial Interests. My first job was in dementia care, where I led the memory clinic. It is so important that people have access to psychological care, including the musical therapy that the hon. Member for Strangford (Jim Shannon) mentioned earlier and reminiscence therapies, and that we treat people holistically —the whole person—and collaborate to ensure we share best practice on treatment.
I am grateful for the opportunity to speak today. I look forward to listening to others’ contributions.
Madam Deputy Speaker (Dame Rosie Winterton)
I remind Members that there is a three-minute time limit on speeches, which will be displayed on the clock here and on the screens for those participating virtually.
A Plan for the NHS and Social Care
Lisa Cameron Excerpts(3 years, 5 months ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (SNP) [V]
It is a privilege to speak in this debate today. I start by congratulating those who have made their maiden speeches today and by thanking all our NHS and care staff across my constituency of East Kilbride, Strathaven and Lesmahagow, including allied health professionals. They have gone the extra mile to meet the demands of the past year in relation to treating both physical and mental health.
As a psychologist, I, along with the Royal College of Psychiatrists, hope that the proposed health and social care Bill will mark a very significant step towards parity of esteem for mental health services. In December 2020, there was an 11% increase in referrals, and the UK household longitudinal study found that during the peak of covid, average mental distress was 8.1% higher than normal levels, so we cannot underestimate the potential tsunami of mental health issues that will require to be treated as a consequence of this pandemic. We also cannot forget that staff have been exposed to significant trauma and will require psychological first aid provision to ensure their wellbeing.
I remain concerned by the lack of a statutory requirement in the Government’s White Paper to have mental health representatives on integrated care systems boards. I fear that failure to do so could result in mental health services being sidelined once again.
Our children have coped in their young lifetimes with one of the biggest adjustments and crises we have ever seen. We must be cognisant of their resilience but also the impact, because they have been dealing with a killer disease that they know can take away their loved ones and have had their educational and social lives turned upside down. Ensuring that the mental health concerns of children are identified, referred and treated is of paramount importance. The Royal College of Psychiatrists found that 1.5 million children are predicted to need new or extra mental health support as a result of the pandemic.
Finally, little has been said about people with disabilities. I hope I do not have to remind Government that a comprehensive reform to health and social care that ignores disabled people would not be comprehensive at all. Levelling up for people with disabilities must be at the heart of the response, and as chair of the all-party parliamentary group for disability, I once again implore Government to have a disability-inclusive covid-19 recovery plan.
Health and Social Care Update
Lisa Cameron Excerpts(3 years, 7 months ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Matt Hancock
I am sure the whole House will agree with every single word that my hon. Friend said. They say that success has many fathers, and Kettering has discovered another extraordinary daughter in the vaccine roll-out. Sarah Gilbert worked on the Ebola vaccine before this one and has played a role in saving many, many thousands of lives over her career in medical research. I have no doubt that she will save many, many more in the future. We all salute her work, and we salute her attitude and her team work too, because that is one of the characteristics that has made it possible to deliver these vaccines so fast.
Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (SNP) [V]
As chair of the all-party parliamentary group on disability, I have been hearing heartbreaking accounts of the disproportionate effect that the pandemic has had on disabled people across the United Kingdom. According to a survey conducted by the Family Fund, 93% of families said that coronavirus had negatively affected disabled or seriously ill children’s mental health. What crucial steps are the Government taking to support the mental health and wellbeing of children and adults with disabilities?
Maternal Mental Health
Lisa Cameron Excerpts(3 years, 7 months ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (SNP) [V]
It is an absolute pleasure to serve under your chairmanship, Sir Edward. I commend the hon. Member for Richmond Park (Sarah Olney) on bringing this absolutely vital debate to Parliament. It is crucial and could not be more timely. Before I begin, I refer to my entry in the register as a clinical psychologist, and thank the British Psychological Society and the Maternal Mental Health Alliance for the work that they have done in this field, among the many other charities and organisations already referred to.
I thank everyone who has spoken so thoroughly today on many issues, including the first crucial 1,001 days, and the importance of digital records, which are essential in ensuring continuity of care. I understand that the Government is bringing in support for family hubs in future, so I am interested to hear from the Minister more about that and how it will support this work. Other issues that have been raised go to the core of mental health stigma and the impact of coronavirus on labour and prenatal care.
Members have spoken eloquently about their own personal experiences. It is absolutely crucial to ensure that we normalise wellbeing and mental health issues, particularly during this most crucial time in people’s lives, and also give due cognisance to the importance of ensuring that people can access services when they need to do so.
The first weeks, months and years of parenthood were absolutely some of the most difficult that I have experienced—fraught with sleepless nights, anxiety about the future and overly high expectations that I placed on myself about the responsibilities of being a new mum. Support is absolutely crucial at these times, and that has just not been available during covid-19.
Before the coronavirus pandemic, more than one in five women experienced mental health problems during pregnancy or in the first post-natal year and, as is true of so much of our lives in the past year, covid-19 has exacerbated those issues. The Baby Loss Awareness Alliance, led by the charity Sands, found that isolation increased during lockdown, with feelings of loneliness impacting 63% of new parents—compared with 38% before the pandemic—and those who had experienced extreme difficulties during birth. If symptoms are allowed to spiral, more severe perinatal mental health issues can be significant and can have long-term effects on mother, baby, father and different members of the family.
Research evidence suggests that the long-term cost of perinatal depression, anxiety and psychosis in the UK is £8.1 billion per year, equivalent to roughly £10,000 for every single birth in the UK each year. While the financial weight of the failure to help new and expectant families is stark, the reality of families having to cope with perinatal mental illness is also heartbreaking, with maternal suicide one of the leading causes of death for women during pregnancy and in the first year after birth.
In summing up, I want to highlight two areas to the Government where I think the situation can be improved. First, pharmacological interventions really have to be matched with high-quality specialist psychological therapies during the perinatal period. Significant steps have been taken towards integrated care across the UK and in the devolved Governments in the past few years, but much more needs to be done to ensure that maternal mental health needs are met in whatever context they first present. That might be in maternity services, adult mental health services, drug and alcohol services, learning disability services or child and adolescent mental health services that are supporting the whole family. Wherever families show signs of needing help, they must be able to access specialist psychological therapies as quickly and easily as possible if we are to ensure the best possible outcome.
That must also apply to specialist perinatal community teams. In many circumstances, these home visit teams are the first and sometimes the last opportunity to spot maternal mental health issues, and they must include individuals with specialist training in clinical psychology. The British Psychological Society has recommended that every specialist perinatal mental health team should include clinical psychology and that every woman identified as requiring a psychological intervention should be offered an assessment and treatment with a clinical psychologist within 28 days. I highlight that recommendation.
In 2020, the Scottish Government invested £1.4 million in specialist community perinatal mental health services, with an additional £1.5 million for infant mental health and maternal and neonatal psychological services across Scotland. I urge the UK Government to set out additional support to what has already been promised in the NHS long-term plan, in the light of the additional and compound need that we have heard about in the debate today, which has set out the impact of covid-19. The need has been exacerbated, and it is crucial that we do not fail families at this time.